Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02833077 · ClinicalTrials.gov registry record · NA
A Safety and Effectiveness Study of JUVÉDERM VOLUMA® XC Injectable Gel for Chin Augmentation
A NA study, sponsored by Allergan.
- Completed
- Registry status
- NA
- Development phase
- 221
- Enrollment target
NCT02833077 is a NA study that has completed, run by Allergan. The registered enrollment target is 221 participants.
The verdict
NCT02833077, a NA study, has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- NA
- Development phase
- 221 participants
- Enrollment target
Study Summary
This is a safety and effectiveness study of JUVÉDERM VOLUMA XC injectable gel for chin augmentation to correct volume deficit in chin retrusion.
Interventions
- DEVICE JUVÉDERM VOLUMA® XC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 221 participants |
| Start Date | 2016-06-28 |
| Est. Completion | 2018-10-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02833077
The ClinicalTrials.gov registry entry for NCT02833077 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 221 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Allergan, which has 314 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which JUVÉDERM VOLUMA® XC is the first listed.
NCT02833077 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02833077 about?
NCT02833077 is a clinical study titled "A Safety and Effectiveness Study of JUVÉDERM VOLUMA® XC Injectable Gel for Chin Augmentation". This is a safety and effectiveness study of JUVÉDERM VOLUMA XC injectable gel for chin augmentation to correct volume deficit in chin retrusion.
What is the current status of trial NCT02833077?
This trial is currently completed. It is a NA study. The enrollment target is 221 participants. The study started on 2016-06-28. Estimated completion is 2018-10-11.
What interventions are being tested in trial NCT02833077?
The interventions under investigation include: JUVÉDERM VOLUMA® XC (DEVICE).
Who is sponsoring clinical trial NCT02833077?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.